Goldman Sachs: Maintains "Buy" rating on BILIBILI-W (09626) with a target price of HK$176.
Bilibili announced its first share buyback plan, which will repurchase $200 million worth of shares over the next two years.
Goldman Sachs released a research report, maintaining a "buy" rating on BILIBILI-W (09626) with an H-share target price of HK$176.
Goldman Sachs stated that Bilibili announced its first share repurchase plan, which will repurchase $200 million worth of stock in the next two years, demonstrating the company's healthy financial condition and ability to generate free cash flow.
The report mentioned that Bilibili achieved quarterly breakeven for the first time, with an adjusted operating profit of 272 million yuan in the third quarter, significantly higher than the bank's forecast by 31%, benefiting from marketing costs in line with expectations and well-controlled research and development expenses; revenue growth is in line with expectations.
Related Articles

US Stock Market Move | Fangdd Network Group Ltd Sponsored ADR Class A(DUO.US) surged 13%, narrowing the month-on-month decline in sales prices of residential properties in top and second-tier cities in August.

DL HOLDINGS GP (01709) further subscribed to 15.10% Class B membership interests of Carmel Reserve LLC.

US Stock Market Move | Novo Nordisk A/S Sponsored ADR Class B (NVO.US) rises more than 2% on positive Phase III trial results of new generation weight-loss drug Cagrilintide.
US Stock Market Move | Fangdd Network Group Ltd Sponsored ADR Class A(DUO.US) surged 13%, narrowing the month-on-month decline in sales prices of residential properties in top and second-tier cities in August.

DL HOLDINGS GP (01709) further subscribed to 15.10% Class B membership interests of Carmel Reserve LLC.

US Stock Market Move | Novo Nordisk A/S Sponsored ADR Class B (NVO.US) rises more than 2% on positive Phase III trial results of new generation weight-loss drug Cagrilintide.
